BMY - Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at Bernstein 38th Annual Strategic Decisions Conference (Transcript)

Bristol-Myers Squibb Company (BMY) Bernstein 38th Annual Strategic Decisions Conference Call June 2, 2022 08:00 ET Company Participants Giovanni Caforio - Chief Executive Officer Samit Hirawat - Chief Medical Officer Conference Call Participants Wimal Kapadia - Bernstein Presentation Wimal Kapadia Good morning, everybody and thank you for joining today. I am Wimal Kapadia, the EU biopharma analyst here at Bernstein. It’s my great pleasure to introduce Giovanni Caforio, CEO of Bristol-Myers Squibb; and Samit Hirawat, Chief Medical Officer at BMS. Thank you for your time. We really appreciate it. Just as a quick reminder, you can ask questions on the – via the Pigeonhole and it’s nice to see we have already got a few questions submitted, so thank you very much. I think with that, we can kick off. I think Giovanni we jump straight into Q&A if that works. Giovanni Caforio That’s perfect. Thank you. Question-and-Answer Session Q

For further details see:

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at Bernstein 38th Annual Strategic Decisions Conference (Transcript)